Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo

Cancer Research
Blake A JacobsonRobert A Kratzke

Abstract

Aberrant hyperactivation of the cap-dependent protein synthesis apparatus has been documented in a wide range of solid tumors, including epithelial carcinomas, but causal linkage has only been established in breast carcinoma. In this report, we sought to determine if targeted disruption of deregulated cap-dependent translation abrogates tumorigenicity and enhances cell death in non-small cell lung cancer (NSCLC). NSCLC cell lines were stably transfected with either wild-type 4E-BP1 (HA-4E-BP1) or the dominant-active mutant 4E-BP1(A37/A46) (HA-TTAA). Transfected NSCLC cells with enhanced translational repression showed pronounced cell death following treatment with gemcitabine. In addition, transfected HA-TTAA and HA-4E-BP1wt proteins suppressed growth in a cloning efficiency assay. NSCLC cells transduced with HA-TTAA also show decreased tumorigenicity in xenograft models. Xenograft tumors expressing HA-TTAA were significantly smaller than control tumors. This work shows that hyperactivation of the translational machinery is necessary for maintenance of the malignant phenotype in NSCLC, identifies the molecular strategy used to activate translation, and supports the development of lung cancer therapies that directly target the c...Continue Reading

References

Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A De Benedetti, R E Rhoads
Dec 20, 1995·Journal of the National Cancer Institute·R A KratzkeF J Kaye
Feb 20, 1995·International Journal of Cancer. Journal International Du Cancer·V KerekatteA De Benedetti
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·I B RosenwaldE V Schmidt
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
May 30, 1998·Annals of Surgery·B D LiA De Benedetti
Jun 11, 1999·Genes & Development·A C GingrasN Sonenberg
May 16, 2000·The Journal of Biological Chemistry·V A PolunovskyP B Bitterman
Jun 29, 2000·Annual Review of Biochemistry·A C GingrasN Sonenberg
Apr 12, 2001·Genes & Development·A C GingrasN Sonenberg
May 3, 2001·Journal of the National Cancer Institute·D G BurbeeJ D Minna
Aug 7, 2003·Current Opinion in Pharmacology·Shile Huang, Peter J Houghton
Apr 20, 2004·Oncogene·Yaël MamaneNahum Sonenberg
Apr 20, 2004·Oncogene·Arrigo De Benedetti, Jeremy R Graff
Apr 20, 2004·Oncogene·Vinagolu K Rajasekhar, Eric C Holland

❮ Previous
Next ❯

Citations

Mar 3, 2011·Nature Reviews. Clinical Oncology·Sarah P Blagden, Anne E Willis
Apr 18, 2012·Oncogene·Y MartineauS Pyronnet
Apr 9, 2009·Journal of the National Cancer Institute·Antonello PunturieriSteven M Dubinett
Dec 20, 2012·Science Signaling·Valentina EvdokimovaArun Seth
May 11, 2012·Molecular Cancer Therapeutics·Peter B Bitterman, Vitaly A Polunovsky
Mar 4, 2008·American Journal of Respiratory and Critical Care Medicine·Cheng-Xiong XuMyung-Haing Cho
Jan 6, 2010·Journal of Oncology·Biljana Culjkovic, Katherine L Borden
Aug 27, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Manish R PatelRobert A Kratzke
Jul 26, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Manish R PatelRobert A Kratzke
Sep 7, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Manish R PatelRobert A Kratzke
Feb 11, 2014·Clinics in Chest Medicine·Gourab ChoudhuryWilliam MacNee
Jul 14, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Nobuhiko SekiKenji Eguchi
Mar 3, 2009·International Journal of Radiation Oncology, Biology, Physics·Ludwig DuboisBradly G Wouters
Oct 10, 2007·Cancer Letters·Saritha C Thumma, Robert A Kratzke
Jul 27, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Mark N KirsteinRobert A Kratzke
Apr 9, 2014·Investigational New Drugs·Esther Z ChenRobert A Kratzke
Jun 15, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kasper M A RouschopBradly G Wouters
Oct 31, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Oshrat Attar-SchneiderMaya Gottfried
Aug 9, 2016·Laboratory Investigation; a Journal of Technical Methods and Pathology·Oshrat Attar-SchneiderMaya Gottfried
Feb 1, 2011·ChemMedChem·Alexey BenyumovMark N Kirstein
May 26, 2018·The European Respiratory Journal·Brian J SandriChris H Wendt
Nov 25, 2020·Investigational New Drugs·Blake A JacobsonRobert A Kratzke
Oct 26, 2010·Molecular Cancer Therapeutics·Chad A DumstorfJeremy R Graff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.